Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 775 of 3173 entries
View as:

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

Phase: N/A Priority: Normal
NCT ID: NCT00414661 Org: User:
Start: 04/30/07 End: 02/29/12 Due: 02/28/13

A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule Formulation

Phase: N/A Priority: Normal
NCT ID: NCT02006277 Org: User:
Start: 12/31/13 End: 03/31/14 Due: 03/31/15

A Study To Evaluate The Effect Of Itraconazole On Pharmacokinetics Of PF-06463922 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02838264 Org: User:
Start: 08/16/16 End: 05/03/17 Due: 05/03/18

Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00838565 Org: User:
Start: 05/20/09 End: 02/02/12 Due: 02/02/13

Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

Phase: N/A Priority: Normal
NCT ID: NCT05466578 Org: User:
Start: - End: - Due: -

Real-World Observational Study Of Zavicefta to Characterize Use Patterns

Phase: N/A Priority: Normal
NCT ID: NCT03923426 Org: User:
Start: 11/27/18 End: 03/28/22 Due: 03/28/23

Renal Impairment Study of PF-06700841

Phase: N/A Priority: Normal
NCT ID: NCT04260464 Org: User:
Start: 07/03/20 End: 05/04/22 Due: 05/04/23

A Single Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00799006 Org: User:
Start: 11/30/08 End: 06/30/09 Due: 06/30/10

Systematic Review And Meta-Analysis Of Psoriasis Treatments.

Phase: N/A Priority: Normal
NCT ID: NCT01425138 Org: User:
Start: 06/30/09 End: 06/30/11 Due: 06/30/12

PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Phase: N/A Priority: Normal
NCT ID: NCT05259397 Org: User:
Start: 03/24/22 End: 09/19/22 Due: 09/19/23

A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT00376168 Org: User:
Start: 08/31/07 End: 10/31/09 Due: 10/31/10

A Study of Tanezumab in Adults With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00876187 Org: User:
Start: 06/15/09 End: 02/01/11 Due: 02/01/12

Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00553254 Org: User:
Start: 02/05/08 End: 07/17/14 Due: 07/17/15

A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT00134264 Org: User:
Start: 07/31/04 End: 06/30/07 Due: 06/30/08

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03895372 Org: User:
Start: 06/27/19 End: 11/26/20 Due: 11/26/21

A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06675188 Org: User:
Start: 01/06/25 End: 07/17/25 Due: 07/17/26

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT02958865 Org: User:
Start: 02/03/17 End: 05/10/21 Due: 05/10/22

A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01968980 Org: User:
Start: 10/23/13 End: 04/15/16 Due: 04/15/17

A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.

Phase: N/A Priority: Normal
NCT ID: NCT01064726 Org: User:
Start: 10/31/09 End: 04/30/10 Due: 04/30/11

Multiple Dose Healthy Volunteer Study of PF-03715455.

Phase: N/A Priority: Normal
NCT ID: NCT01186757 Org: User:
Start: 08/31/10 End: 01/31/11 Due: 01/31/12

Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)

Phase: N/A Priority: Normal
NCT ID: NCT00751478 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

Phase: N/A Priority: Normal
NCT ID: NCT02367456 Org: User:
Start: 04/28/15 End: 03/07/22 Due: 03/07/23

A Pharmacokinetic Study Comparing PF-05280014 And Trastuzumab In Healthy Male Volunteers (REFLECTIONS B327-01)

Phase: N/A Priority: Normal
NCT ID: NCT01603264 Org: User:
Start: 05/31/12 End: 12/31/12 Due: 12/31/13

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV

Phase: N/A Priority: Normal
NCT ID: NCT00802854 Org: User:
Start: 03/02/12 End: 05/20/16 Due: 05/20/17

The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.

Phase: N/A Priority: Normal
NCT ID: NCT00037219 Org: User:
Start: 08/31/01 End: 11/30/02 Due: 11/30/03